The latest closing stock price for Alnylam Pharmaceuticals as of May 28, 2025 is 285.56.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $46,514 today, roughly 47 times their original investment - a 20.18% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 6.6% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 48.4% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 253.18.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $46,514 today, roughly 47 times their original investment - a 20.18% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 6.6% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 48.4% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 253.18.